nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CES1—Tamoxifen—pancreatic cancer	0.249	0.345	CbGbCtD
Rufinamide—CES1—Irinotecan—pancreatic cancer	0.191	0.265	CbGbCtD
Rufinamide—CYP2E1—Dacarbazine—pancreatic cancer	0.061	0.0845	CbGbCtD
Rufinamide—CYP2E1—Tamoxifen—pancreatic cancer	0.0485	0.0672	CbGbCtD
Rufinamide—ALB—Erlotinib—pancreatic cancer	0.0399	0.0553	CbGbCtD
Rufinamide—ALB—Irinotecan—pancreatic cancer	0.036	0.0499	CbGbCtD
Rufinamide—ALB—Fluorouracil—pancreatic cancer	0.0346	0.0479	CbGbCtD
Rufinamide—CYP3A4—Tamoxifen—pancreatic cancer	0.0147	0.0204	CbGbCtD
Rufinamide—CYP3A4—Erlotinib—pancreatic cancer	0.0125	0.0173	CbGbCtD
Rufinamide—CYP3A4—Irinotecan—pancreatic cancer	0.0113	0.0156	CbGbCtD
Rufinamide—CYP3A4—Docetaxel—pancreatic cancer	0.00827	0.0115	CbGbCtD
Rufinamide—CYP3A4—Sunitinib—pancreatic cancer	0.00824	0.0114	CbGbCtD
Rufinamide—CYP3A4—Doxorubicin—pancreatic cancer	0.00617	0.00854	CbGbCtD
Rufinamide—Decreased appetite—Sunitinib—pancreatic cancer	0.000399	0.00243	CcSEcCtD
Rufinamide—Leukopenia—Fluorouracil—pancreatic cancer	0.000397	0.00242	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000396	0.00241	CcSEcCtD
Rufinamide—Fatigue—Sunitinib—pancreatic cancer	0.000396	0.00241	CcSEcCtD
Rufinamide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000395	0.0024	CcSEcCtD
Rufinamide—Constipation—Sunitinib—pancreatic cancer	0.000393	0.00239	CcSEcCtD
Rufinamide—Lymphadenopathy—Doxorubicin—pancreatic cancer	0.000389	0.00237	CcSEcCtD
Rufinamide—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000388	0.00236	CcSEcCtD
Rufinamide—Epistaxis—Docetaxel—pancreatic cancer	0.000387	0.00235	CcSEcCtD
Rufinamide—Asthenia—Tamoxifen—pancreatic cancer	0.000385	0.00234	CcSEcCtD
Rufinamide—Convulsion—Fluorouracil—pancreatic cancer	0.000385	0.00234	CcSEcCtD
Rufinamide—Increased appetite—Epirubicin—pancreatic cancer	0.000382	0.00232	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000382	0.00232	CcSEcCtD
Rufinamide—Asthenia—Erlotinib—pancreatic cancer	0.000381	0.00231	CcSEcCtD
Rufinamide—Pruritus—Tamoxifen—pancreatic cancer	0.000379	0.00231	CcSEcCtD
Rufinamide—Infection—Irinotecan—pancreatic cancer	0.000376	0.00228	CcSEcCtD
Rufinamide—Pruritus—Erlotinib—pancreatic cancer	0.000375	0.00228	CcSEcCtD
Rufinamide—Nervous system disorder—Irinotecan—pancreatic cancer	0.000371	0.00226	CcSEcCtD
Rufinamide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00037	0.00225	CcSEcCtD
Rufinamide—Rhinitis—Docetaxel—pancreatic cancer	0.000369	0.00224	CcSEcCtD
Rufinamide—Diarrhoea—Tamoxifen—pancreatic cancer	0.000367	0.00223	CcSEcCtD
Rufinamide—Infection—Gemcitabine—pancreatic cancer	0.000366	0.00223	CcSEcCtD
Rufinamide—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000363	0.00221	CcSEcCtD
Rufinamide—Diarrhoea—Erlotinib—pancreatic cancer	0.000363	0.00221	CcSEcCtD
Rufinamide—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000361	0.0022	CcSEcCtD
Rufinamide—Urethral disorder—Docetaxel—pancreatic cancer	0.000361	0.00219	CcSEcCtD
Rufinamide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000361	0.00219	CcSEcCtD
Rufinamide—Anorexia—Irinotecan—pancreatic cancer	0.000361	0.00219	CcSEcCtD
Rufinamide—Infection—Fluorouracil—pancreatic cancer	0.00036	0.00219	CcSEcCtD
Rufinamide—Diplopia—Epirubicin—pancreatic cancer	0.000359	0.00218	CcSEcCtD
Rufinamide—Skin disorder—Gemcitabine—pancreatic cancer	0.000358	0.00218	CcSEcCtD
Rufinamide—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000355	0.00216	CcSEcCtD
Rufinamide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000355	0.00216	CcSEcCtD
Rufinamide—Dizziness—Tamoxifen—pancreatic cancer	0.000355	0.00216	CcSEcCtD
Rufinamide—Increased appetite—Doxorubicin—pancreatic cancer	0.000353	0.00215	CcSEcCtD
Rufinamide—Anorexia—Gemcitabine—pancreatic cancer	0.000351	0.00214	CcSEcCtD
Rufinamide—Dizziness—Erlotinib—pancreatic cancer	0.000351	0.00213	CcSEcCtD
Rufinamide—Anorexia—Fluorouracil—pancreatic cancer	0.000345	0.0021	CcSEcCtD
Rufinamide—Eye disorder—Docetaxel—pancreatic cancer	0.000344	0.00209	CcSEcCtD
Rufinamide—Insomnia—Irinotecan—pancreatic cancer	0.000342	0.00208	CcSEcCtD
Rufinamide—Cardiac disorder—Docetaxel—pancreatic cancer	0.000342	0.00208	CcSEcCtD
Rufinamide—Vomiting—Tamoxifen—pancreatic cancer	0.000341	0.00207	CcSEcCtD
Rufinamide—Hypersensitivity—Sunitinib—pancreatic cancer	0.000338	0.00206	CcSEcCtD
Rufinamide—Rash—Tamoxifen—pancreatic cancer	0.000338	0.00206	CcSEcCtD
Rufinamide—Dermatitis—Tamoxifen—pancreatic cancer	0.000338	0.00205	CcSEcCtD
Rufinamide—Ataxia—Epirubicin—pancreatic cancer	0.000337	0.00205	CcSEcCtD
Rufinamide—Vomiting—Erlotinib—pancreatic cancer	0.000337	0.00205	CcSEcCtD
Rufinamide—Somnolence—Irinotecan—pancreatic cancer	0.000336	0.00204	CcSEcCtD
Rufinamide—Headache—Tamoxifen—pancreatic cancer	0.000336	0.00204	CcSEcCtD
Rufinamide—Rash—Erlotinib—pancreatic cancer	0.000334	0.00203	CcSEcCtD
Rufinamide—Dermatitis—Erlotinib—pancreatic cancer	0.000334	0.00203	CcSEcCtD
Rufinamide—Insomnia—Gemcitabine—pancreatic cancer	0.000333	0.00203	CcSEcCtD
Rufinamide—Dyspepsia—Irinotecan—pancreatic cancer	0.000333	0.00202	CcSEcCtD
Rufinamide—Immune system disorder—Docetaxel—pancreatic cancer	0.000332	0.00202	CcSEcCtD
Rufinamide—Headache—Erlotinib—pancreatic cancer	0.000332	0.00202	CcSEcCtD
Rufinamide—Diplopia—Doxorubicin—pancreatic cancer	0.000332	0.00202	CcSEcCtD
Rufinamide—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000332	0.00202	CcSEcCtD
Rufinamide—Asthenia—Sunitinib—pancreatic cancer	0.000329	0.002	CcSEcCtD
Rufinamide—Decreased appetite—Irinotecan—pancreatic cancer	0.000329	0.002	CcSEcCtD
Rufinamide—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000328	0.00199	CcSEcCtD
Rufinamide—Insomnia—Fluorouracil—pancreatic cancer	0.000328	0.00199	CcSEcCtD
Rufinamide—Somnolence—Gemcitabine—pancreatic cancer	0.000328	0.00199	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000327	0.00199	CcSEcCtD
Rufinamide—Fatigue—Irinotecan—pancreatic cancer	0.000326	0.00198	CcSEcCtD
Rufinamide—Pruritus—Sunitinib—pancreatic cancer	0.000325	0.00198	CcSEcCtD
Rufinamide—Breast disorder—Epirubicin—pancreatic cancer	0.000324	0.00197	CcSEcCtD
Rufinamide—Constipation—Irinotecan—pancreatic cancer	0.000323	0.00197	CcSEcCtD
Rufinamide—Mental disorder—Docetaxel—pancreatic cancer	0.000322	0.00196	CcSEcCtD
Rufinamide—Somnolence—Fluorouracil—pancreatic cancer	0.000322	0.00196	CcSEcCtD
Rufinamide—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000321	0.00195	CcSEcCtD
Rufinamide—Malnutrition—Docetaxel—pancreatic cancer	0.00032	0.00195	CcSEcCtD
Rufinamide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00032	0.00195	CcSEcCtD
Rufinamide—Dyspepsia—Fluorouracil—pancreatic cancer	0.000319	0.00194	CcSEcCtD
Rufinamide—Nausea—Tamoxifen—pancreatic cancer	0.000318	0.00194	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000318	0.00193	CcSEcCtD
Rufinamide—Fatigue—Gemcitabine—pancreatic cancer	0.000318	0.00193	CcSEcCtD
Rufinamide—Constipation—Gemcitabine—pancreatic cancer	0.000315	0.00192	CcSEcCtD
Rufinamide—Nausea—Erlotinib—pancreatic cancer	0.000315	0.00192	CcSEcCtD
Rufinamide—Decreased appetite—Fluorouracil—pancreatic cancer	0.000315	0.00191	CcSEcCtD
Rufinamide—Diarrhoea—Sunitinib—pancreatic cancer	0.000314	0.00191	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000313	0.0019	CcSEcCtD
Rufinamide—Ataxia—Doxorubicin—pancreatic cancer	0.000312	0.0019	CcSEcCtD
Rufinamide—Influenza—Epirubicin—pancreatic cancer	0.00031	0.00189	CcSEcCtD
Rufinamide—Back pain—Docetaxel—pancreatic cancer	0.00031	0.00188	CcSEcCtD
Rufinamide—Dizziness—Sunitinib—pancreatic cancer	0.000304	0.00185	CcSEcCtD
Rufinamide—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000303	0.00184	CcSEcCtD
Rufinamide—Breast disorder—Doxorubicin—pancreatic cancer	0.0003	0.00182	CcSEcCtD
Rufinamide—Bronchitis—Epirubicin—pancreatic cancer	0.000298	0.00181	CcSEcCtD
Rufinamide—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000297	0.00181	CcSEcCtD
Rufinamide—Anaemia—Docetaxel—pancreatic cancer	0.000296	0.0018	CcSEcCtD
Rufinamide—Vomiting—Sunitinib—pancreatic cancer	0.000292	0.00178	CcSEcCtD
Rufinamide—Neutropenia—Epirubicin—pancreatic cancer	0.00029	0.00176	CcSEcCtD
Rufinamide—Dysuria—Epirubicin—pancreatic cancer	0.00029	0.00176	CcSEcCtD
Rufinamide—Rash—Sunitinib—pancreatic cancer	0.00029	0.00176	CcSEcCtD
Rufinamide—Dermatitis—Sunitinib—pancreatic cancer	0.000289	0.00176	CcSEcCtD
Rufinamide—Headache—Sunitinib—pancreatic cancer	0.000288	0.00175	CcSEcCtD
Rufinamide—Influenza—Doxorubicin—pancreatic cancer	0.000287	0.00174	CcSEcCtD
Rufinamide—Leukopenia—Docetaxel—pancreatic cancer	0.000287	0.00174	CcSEcCtD
Rufinamide—Pollakiuria—Epirubicin—pancreatic cancer	0.000287	0.00174	CcSEcCtD
Rufinamide—Weight decreased—Epirubicin—pancreatic cancer	0.000281	0.00171	CcSEcCtD
Rufinamide—Hypersensitivity—Irinotecan—pancreatic cancer	0.000279	0.00169	CcSEcCtD
Rufinamide—Pneumonia—Epirubicin—pancreatic cancer	0.000278	0.00169	CcSEcCtD
Rufinamide—Convulsion—Docetaxel—pancreatic cancer	0.000278	0.00169	CcSEcCtD
Rufinamide—Infestation—Epirubicin—pancreatic cancer	0.000277	0.00168	CcSEcCtD
Rufinamide—Infestation NOS—Epirubicin—pancreatic cancer	0.000277	0.00168	CcSEcCtD
Rufinamide—Bronchitis—Doxorubicin—pancreatic cancer	0.000276	0.00168	CcSEcCtD
Rufinamide—Nausea—Sunitinib—pancreatic cancer	0.000273	0.00166	CcSEcCtD
Rufinamide—Asthenia—Irinotecan—pancreatic cancer	0.000271	0.00165	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000271	0.00165	CcSEcCtD
Rufinamide—Dysuria—Doxorubicin—pancreatic cancer	0.000268	0.00163	CcSEcCtD
Rufinamide—Neutropenia—Doxorubicin—pancreatic cancer	0.000268	0.00163	CcSEcCtD
Rufinamide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000267	0.00162	CcSEcCtD
Rufinamide—Pollakiuria—Doxorubicin—pancreatic cancer	0.000265	0.00161	CcSEcCtD
Rufinamide—Asthenia—Gemcitabine—pancreatic cancer	0.000264	0.00161	CcSEcCtD
Rufinamide—Haematuria—Epirubicin—pancreatic cancer	0.000264	0.0016	CcSEcCtD
Rufinamide—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000262	0.00159	CcSEcCtD
Rufinamide—Epistaxis—Epirubicin—pancreatic cancer	0.000261	0.00159	CcSEcCtD
Rufinamide—Pruritus—Gemcitabine—pancreatic cancer	0.000261	0.00159	CcSEcCtD
Rufinamide—Infection—Docetaxel—pancreatic cancer	0.00026	0.00158	CcSEcCtD
Rufinamide—Weight decreased—Doxorubicin—pancreatic cancer	0.00026	0.00158	CcSEcCtD
Rufinamide—Sinusitis—Epirubicin—pancreatic cancer	0.000259	0.00158	CcSEcCtD
Rufinamide—Diarrhoea—Irinotecan—pancreatic cancer	0.000259	0.00157	CcSEcCtD
Rufinamide—Pneumonia—Doxorubicin—pancreatic cancer	0.000257	0.00156	CcSEcCtD
Rufinamide—Nervous system disorder—Docetaxel—pancreatic cancer	0.000256	0.00156	CcSEcCtD
Rufinamide—Pruritus—Fluorouracil—pancreatic cancer	0.000256	0.00156	CcSEcCtD
Rufinamide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000256	0.00156	CcSEcCtD
Rufinamide—Infestation NOS—Doxorubicin—pancreatic cancer	0.000256	0.00156	CcSEcCtD
Rufinamide—Infestation—Doxorubicin—pancreatic cancer	0.000256	0.00156	CcSEcCtD
Rufinamide—Skin disorder—Docetaxel—pancreatic cancer	0.000254	0.00154	CcSEcCtD
Rufinamide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000252	0.00153	CcSEcCtD
Rufinamide—Dizziness—Irinotecan—pancreatic cancer	0.00025	0.00152	CcSEcCtD
Rufinamide—Anorexia—Docetaxel—pancreatic cancer	0.000249	0.00152	CcSEcCtD
Rufinamide—Rhinitis—Epirubicin—pancreatic cancer	0.000249	0.00151	CcSEcCtD
Rufinamide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000248	0.00151	CcSEcCtD
Rufinamide—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000245	0.00149	CcSEcCtD
Rufinamide—Haematuria—Doxorubicin—pancreatic cancer	0.000244	0.00148	CcSEcCtD
Rufinamide—Urethral disorder—Epirubicin—pancreatic cancer	0.000243	0.00148	CcSEcCtD
Rufinamide—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000242	0.00147	CcSEcCtD
Rufinamide—Epistaxis—Doxorubicin—pancreatic cancer	0.000241	0.00147	CcSEcCtD
Rufinamide—Vomiting—Irinotecan—pancreatic cancer	0.000241	0.00146	CcSEcCtD
Rufinamide—Sinusitis—Doxorubicin—pancreatic cancer	0.00024	0.00146	CcSEcCtD
Rufinamide—Dizziness—Fluorouracil—pancreatic cancer	0.00024	0.00146	CcSEcCtD
Rufinamide—Rash—Irinotecan—pancreatic cancer	0.000239	0.00145	CcSEcCtD
Rufinamide—Dermatitis—Irinotecan—pancreatic cancer	0.000238	0.00145	CcSEcCtD
Rufinamide—Headache—Irinotecan—pancreatic cancer	0.000237	0.00144	CcSEcCtD
Rufinamide—Insomnia—Docetaxel—pancreatic cancer	0.000237	0.00144	CcSEcCtD
Rufinamide—Vomiting—Gemcitabine—pancreatic cancer	0.000234	0.00142	CcSEcCtD
Rufinamide—Somnolence—Docetaxel—pancreatic cancer	0.000232	0.00141	CcSEcCtD
Rufinamide—Rash—Gemcitabine—pancreatic cancer	0.000232	0.00141	CcSEcCtD
Rufinamide—Dermatitis—Gemcitabine—pancreatic cancer	0.000232	0.00141	CcSEcCtD
Rufinamide—Eye disorder—Epirubicin—pancreatic cancer	0.000232	0.00141	CcSEcCtD
Rufinamide—Headache—Gemcitabine—pancreatic cancer	0.000231	0.0014	CcSEcCtD
Rufinamide—Cardiac disorder—Epirubicin—pancreatic cancer	0.00023	0.0014	CcSEcCtD
Rufinamide—Vomiting—Fluorouracil—pancreatic cancer	0.00023	0.0014	CcSEcCtD
Rufinamide—Rhinitis—Doxorubicin—pancreatic cancer	0.00023	0.0014	CcSEcCtD
Rufinamide—Dyspepsia—Docetaxel—pancreatic cancer	0.00023	0.0014	CcSEcCtD
Rufinamide—Rash—Fluorouracil—pancreatic cancer	0.000228	0.00139	CcSEcCtD
Rufinamide—Dermatitis—Fluorouracil—pancreatic cancer	0.000228	0.00139	CcSEcCtD
Rufinamide—Decreased appetite—Docetaxel—pancreatic cancer	0.000227	0.00138	CcSEcCtD
Rufinamide—Headache—Fluorouracil—pancreatic cancer	0.000227	0.00138	CcSEcCtD
Rufinamide—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000227	0.00138	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000226	0.00137	CcSEcCtD
Rufinamide—Fatigue—Docetaxel—pancreatic cancer	0.000225	0.00137	CcSEcCtD
Rufinamide—Urethral disorder—Doxorubicin—pancreatic cancer	0.000225	0.00137	CcSEcCtD
Rufinamide—Nausea—Irinotecan—pancreatic cancer	0.000225	0.00137	CcSEcCtD
Rufinamide—Immune system disorder—Epirubicin—pancreatic cancer	0.000224	0.00136	CcSEcCtD
Rufinamide—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000224	0.00136	CcSEcCtD
Rufinamide—Constipation—Docetaxel—pancreatic cancer	0.000224	0.00136	CcSEcCtD
Rufinamide—Nausea—Gemcitabine—pancreatic cancer	0.000219	0.00133	CcSEcCtD
Rufinamide—Mental disorder—Epirubicin—pancreatic cancer	0.000217	0.00132	CcSEcCtD
Rufinamide—Malnutrition—Epirubicin—pancreatic cancer	0.000216	0.00131	CcSEcCtD
Rufinamide—Nausea—Fluorouracil—pancreatic cancer	0.000215	0.00131	CcSEcCtD
Rufinamide—Eye disorder—Doxorubicin—pancreatic cancer	0.000215	0.00131	CcSEcCtD
Rufinamide—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000213	0.0013	CcSEcCtD
Rufinamide—Back pain—Epirubicin—pancreatic cancer	0.000209	0.00127	CcSEcCtD
Rufinamide—Immune system disorder—Doxorubicin—pancreatic cancer	0.000207	0.00126	CcSEcCtD
Rufinamide—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000207	0.00126	CcSEcCtD
Rufinamide—Vision blurred—Epirubicin—pancreatic cancer	0.000204	0.00124	CcSEcCtD
Rufinamide—Mental disorder—Doxorubicin—pancreatic cancer	0.000201	0.00122	CcSEcCtD
Rufinamide—Malnutrition—Doxorubicin—pancreatic cancer	0.0002	0.00122	CcSEcCtD
Rufinamide—Anaemia—Epirubicin—pancreatic cancer	0.0002	0.00121	CcSEcCtD
Rufinamide—Agitation—Epirubicin—pancreatic cancer	0.000199	0.00121	CcSEcCtD
Rufinamide—Vertigo—Epirubicin—pancreatic cancer	0.000194	0.00118	CcSEcCtD
Rufinamide—Leukopenia—Epirubicin—pancreatic cancer	0.000193	0.00118	CcSEcCtD
Rufinamide—Back pain—Doxorubicin—pancreatic cancer	0.000193	0.00118	CcSEcCtD
Rufinamide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000193	0.00117	CcSEcCtD
Rufinamide—Vision blurred—Doxorubicin—pancreatic cancer	0.000188	0.00115	CcSEcCtD
Rufinamide—Asthenia—Docetaxel—pancreatic cancer	0.000188	0.00114	CcSEcCtD
Rufinamide—Convulsion—Epirubicin—pancreatic cancer	0.000187	0.00114	CcSEcCtD
Rufinamide—Pruritus—Docetaxel—pancreatic cancer	0.000185	0.00112	CcSEcCtD
Rufinamide—Anaemia—Doxorubicin—pancreatic cancer	0.000185	0.00112	CcSEcCtD
Rufinamide—Agitation—Doxorubicin—pancreatic cancer	0.000184	0.00112	CcSEcCtD
Rufinamide—Anxiety—Epirubicin—pancreatic cancer	0.000183	0.00111	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000183	0.00111	CcSEcCtD
Rufinamide—Vertigo—Doxorubicin—pancreatic cancer	0.00018	0.00109	CcSEcCtD
Rufinamide—Leukopenia—Doxorubicin—pancreatic cancer	0.000179	0.00109	CcSEcCtD
Rufinamide—Diarrhoea—Docetaxel—pancreatic cancer	0.000179	0.00109	CcSEcCtD
Rufinamide—Infection—Epirubicin—pancreatic cancer	0.000175	0.00107	CcSEcCtD
Rufinamide—Convulsion—Doxorubicin—pancreatic cancer	0.000173	0.00105	CcSEcCtD
Rufinamide—Nervous system disorder—Epirubicin—pancreatic cancer	0.000173	0.00105	CcSEcCtD
Rufinamide—Dizziness—Docetaxel—pancreatic cancer	0.000173	0.00105	CcSEcCtD
Rufinamide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000173	0.00105	CcSEcCtD
Rufinamide—Skin disorder—Epirubicin—pancreatic cancer	0.000171	0.00104	CcSEcCtD
Rufinamide—Anxiety—Doxorubicin—pancreatic cancer	0.00017	0.00103	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000169	0.00103	CcSEcCtD
Rufinamide—Anorexia—Epirubicin—pancreatic cancer	0.000168	0.00102	CcSEcCtD
Rufinamide—Vomiting—Docetaxel—pancreatic cancer	0.000166	0.00101	CcSEcCtD
Rufinamide—Rash—Docetaxel—pancreatic cancer	0.000165	0.001	CcSEcCtD
Rufinamide—Dermatitis—Docetaxel—pancreatic cancer	0.000165	0.001	CcSEcCtD
Rufinamide—Headache—Docetaxel—pancreatic cancer	0.000164	0.000996	CcSEcCtD
Rufinamide—Infection—Doxorubicin—pancreatic cancer	0.000162	0.000986	CcSEcCtD
Rufinamide—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00016	0.000973	CcSEcCtD
Rufinamide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00016	0.000972	CcSEcCtD
Rufinamide—Insomnia—Epirubicin—pancreatic cancer	0.00016	0.00097	CcSEcCtD
Rufinamide—Skin disorder—Doxorubicin—pancreatic cancer	0.000159	0.000964	CcSEcCtD
Rufinamide—Somnolence—Epirubicin—pancreatic cancer	0.000157	0.000953	CcSEcCtD
Rufinamide—Anorexia—Doxorubicin—pancreatic cancer	0.000156	0.000946	CcSEcCtD
Rufinamide—Nausea—Docetaxel—pancreatic cancer	0.000155	0.000944	CcSEcCtD
Rufinamide—Dyspepsia—Epirubicin—pancreatic cancer	0.000155	0.000944	CcSEcCtD
Rufinamide—Decreased appetite—Epirubicin—pancreatic cancer	0.000153	0.000932	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000152	0.000926	CcSEcCtD
Rufinamide—Fatigue—Epirubicin—pancreatic cancer	0.000152	0.000925	CcSEcCtD
Rufinamide—Constipation—Epirubicin—pancreatic cancer	0.000151	0.000917	CcSEcCtD
Rufinamide—Insomnia—Doxorubicin—pancreatic cancer	0.000148	0.000897	CcSEcCtD
Rufinamide—Somnolence—Doxorubicin—pancreatic cancer	0.000145	0.000882	CcSEcCtD
Rufinamide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000144	0.000873	CcSEcCtD
Rufinamide—Decreased appetite—Doxorubicin—pancreatic cancer	0.000142	0.000863	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000141	0.000857	CcSEcCtD
Rufinamide—Fatigue—Doxorubicin—pancreatic cancer	0.000141	0.000855	CcSEcCtD
Rufinamide—Constipation—Doxorubicin—pancreatic cancer	0.00014	0.000849	CcSEcCtD
Rufinamide—Hypersensitivity—Epirubicin—pancreatic cancer	0.00013	0.00079	CcSEcCtD
Rufinamide—Asthenia—Epirubicin—pancreatic cancer	0.000127	0.000769	CcSEcCtD
Rufinamide—Pruritus—Epirubicin—pancreatic cancer	0.000125	0.000759	CcSEcCtD
Rufinamide—Diarrhoea—Epirubicin—pancreatic cancer	0.000121	0.000734	CcSEcCtD
Rufinamide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00012	0.000731	CcSEcCtD
Rufinamide—Asthenia—Doxorubicin—pancreatic cancer	0.000117	0.000712	CcSEcCtD
Rufinamide—Dizziness—Epirubicin—pancreatic cancer	0.000117	0.000709	CcSEcCtD
Rufinamide—Pruritus—Doxorubicin—pancreatic cancer	0.000115	0.000702	CcSEcCtD
Rufinamide—Vomiting—Epirubicin—pancreatic cancer	0.000112	0.000682	CcSEcCtD
Rufinamide—Diarrhoea—Doxorubicin—pancreatic cancer	0.000112	0.000679	CcSEcCtD
Rufinamide—Rash—Epirubicin—pancreatic cancer	0.000111	0.000676	CcSEcCtD
Rufinamide—Dermatitis—Epirubicin—pancreatic cancer	0.000111	0.000676	CcSEcCtD
Rufinamide—Headache—Epirubicin—pancreatic cancer	0.00011	0.000672	CcSEcCtD
Rufinamide—Dizziness—Doxorubicin—pancreatic cancer	0.000108	0.000656	CcSEcCtD
Rufinamide—Nausea—Epirubicin—pancreatic cancer	0.000105	0.000637	CcSEcCtD
Rufinamide—Vomiting—Doxorubicin—pancreatic cancer	0.000104	0.000631	CcSEcCtD
Rufinamide—Rash—Doxorubicin—pancreatic cancer	0.000103	0.000626	CcSEcCtD
Rufinamide—Dermatitis—Doxorubicin—pancreatic cancer	0.000103	0.000625	CcSEcCtD
Rufinamide—Headache—Doxorubicin—pancreatic cancer	0.000102	0.000622	CcSEcCtD
Rufinamide—Nausea—Doxorubicin—pancreatic cancer	9.69e-05	0.000589	CcSEcCtD
Rufinamide—SCN1A—Axon guidance—EGFR—pancreatic cancer	5.73e-05	0.000504	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—MMP9—pancreatic cancer	5.71e-05	0.000502	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—EGFR—pancreatic cancer	5.71e-05	0.000502	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MET—pancreatic cancer	5.68e-05	0.000499	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—HRAS—pancreatic cancer	5.62e-05	0.000494	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—KRAS—pancreatic cancer	5.62e-05	0.000494	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—KRAS—pancreatic cancer	5.62e-05	0.000494	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CTNNB1—pancreatic cancer	5.57e-05	0.00049	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HIF1A—pancreatic cancer	5.51e-05	0.000484	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TSC2—pancreatic cancer	5.5e-05	0.000483	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NOTCH1—pancreatic cancer	5.47e-05	0.00048	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—MMP9—pancreatic cancer	5.47e-05	0.00048	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TNF—pancreatic cancer	5.44e-05	0.000478	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—KRAS—pancreatic cancer	5.42e-05	0.000476	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—KRAS—pancreatic cancer	5.42e-05	0.000476	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—KRAS—pancreatic cancer	5.39e-05	0.000474	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—APOE—pancreatic cancer	5.38e-05	0.000473	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CTNNB1—pancreatic cancer	5.36e-05	0.000471	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CTNNB1—pancreatic cancer	5.36e-05	0.000471	CbGpPWpGaD
Rufinamide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	5.32e-05	0.000468	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KDR—pancreatic cancer	5.27e-05	0.000463	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—SRC—pancreatic cancer	5.27e-05	0.000463	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MMP9—pancreatic cancer	5.25e-05	0.000462	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MMP9—pancreatic cancer	5.25e-05	0.000462	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—HRAS—pancreatic cancer	5.2e-05	0.000457	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—VEGFA—pancreatic cancer	5.17e-05	0.000455	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TNF—pancreatic cancer	5.17e-05	0.000455	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CTNNB1—pancreatic cancer	5.16e-05	0.000454	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CTNNB1—pancreatic cancer	5.16e-05	0.000454	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PPARG—pancreatic cancer	5.16e-05	0.000453	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—VEGFA—pancreatic cancer	5.13e-05	0.000451	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—STAT3—pancreatic cancer	5.08e-05	0.000447	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—NRAS—pancreatic cancer	5.07e-05	0.000445	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MMP9—pancreatic cancer	5.06e-05	0.000445	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MMP9—pancreatic cancer	5.06e-05	0.000445	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—SRC—pancreatic cancer	5.04e-05	0.000443	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NFKBIA—pancreatic cancer	5.01e-05	0.000441	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—HRAS—pancreatic cancer	5.01e-05	0.000441	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MMP9—pancreatic cancer	4.99e-05	0.000438	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—HRAS—pancreatic cancer	4.97e-05	0.000437	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—AKT1—pancreatic cancer	4.97e-05	0.000436	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NOTCH1—pancreatic cancer	4.97e-05	0.000436	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	4.93e-05	0.000433	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—VEGFA—pancreatic cancer	4.91e-05	0.000431	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—STAT3—pancreatic cancer	4.86e-05	0.000427	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CG—pancreatic cancer	4.86e-05	0.000427	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—NRAS—pancreatic cancer	4.86e-05	0.000427	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—NRAS—pancreatic cancer	4.85e-05	0.000426	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—SRC—pancreatic cancer	4.84e-05	0.000426	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—SRC—pancreatic cancer	4.84e-05	0.000426	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGF—pancreatic cancer	4.8e-05	0.000422	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—HRAS—pancreatic cancer	4.77e-05	0.00042	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—HRAS—pancreatic cancer	4.77e-05	0.00042	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—TGFB1—pancreatic cancer	4.75e-05	0.000417	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP2—pancreatic cancer	4.74e-05	0.000416	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—VEGFA—pancreatic cancer	4.71e-05	0.000414	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—VEGFA—pancreatic cancer	4.71e-05	0.000414	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TGFB1—pancreatic cancer	4.71e-05	0.000414	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—STAT3—pancreatic cancer	4.67e-05	0.00041	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—STAT3—pancreatic cancer	4.67e-05	0.00041	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—SRC—pancreatic cancer	4.67e-05	0.00041	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—SRC—pancreatic cancer	4.67e-05	0.00041	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—NRAS—pancreatic cancer	4.66e-05	0.000409	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—NRAS—pancreatic cancer	4.66e-05	0.000409	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EGFR—pancreatic cancer	4.62e-05	0.000406	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—HRAS—pancreatic cancer	4.6e-05	0.000405	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—HRAS—pancreatic cancer	4.6e-05	0.000405	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—SRC—pancreatic cancer	4.6e-05	0.000404	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—HRAS—pancreatic cancer	4.58e-05	0.000403	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—pancreatic cancer	4.56e-05	0.000401	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—VEGFA—pancreatic cancer	4.55e-05	0.0004	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—VEGFA—pancreatic cancer	4.55e-05	0.0004	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	4.52e-05	0.000398	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TGFB1—pancreatic cancer	4.5e-05	0.000396	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—STAT3—pancreatic cancer	4.5e-05	0.000396	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—STAT3—pancreatic cancer	4.5e-05	0.000396	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—NRAS—pancreatic cancer	4.49e-05	0.000395	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—NRAS—pancreatic cancer	4.49e-05	0.000395	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—VEGFA—pancreatic cancer	4.48e-05	0.000394	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—AKT1—pancreatic cancer	4.43e-05	0.000389	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—NRAS—pancreatic cancer	4.42e-05	0.000389	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EGFR—pancreatic cancer	4.42e-05	0.000389	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EGFR—pancreatic cancer	4.42e-05	0.000388	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TNF—pancreatic cancer	4.4e-05	0.000387	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—KRAS—pancreatic cancer	4.36e-05	0.000383	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TGFB1—pancreatic cancer	4.33e-05	0.00038	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TGFB1—pancreatic cancer	4.33e-05	0.00038	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CD—pancreatic cancer	4.27e-05	0.000375	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EGFR—pancreatic cancer	4.24e-05	0.000373	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EGFR—pancreatic cancer	4.24e-05	0.000373	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.23e-05	0.000372	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TNF—pancreatic cancer	4.21e-05	0.00037	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—KRAS—pancreatic cancer	4.18e-05	0.000367	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TGFB1—pancreatic cancer	4.17e-05	0.000367	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TGFB1—pancreatic cancer	4.17e-05	0.000367	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—KRAS—pancreatic cancer	4.17e-05	0.000367	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	4.11e-05	0.000361	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EGFR—pancreatic cancer	4.09e-05	0.00036	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EGFR—pancreatic cancer	4.09e-05	0.00036	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—AKT1—pancreatic cancer	4.05e-05	0.000356	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TNF—pancreatic cancer	4.04e-05	0.000355	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TNF—pancreatic cancer	4.04e-05	0.000355	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—EGFR—pancreatic cancer	4.03e-05	0.000354	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—KRAS—pancreatic cancer	4.01e-05	0.000352	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—KRAS—pancreatic cancer	4.01e-05	0.000352	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TNF—pancreatic cancer	3.9e-05	0.000343	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TNF—pancreatic cancer	3.9e-05	0.000343	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.88e-05	0.000341	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—KRAS—pancreatic cancer	3.87e-05	0.00034	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—KRAS—pancreatic cancer	3.87e-05	0.00034	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—PIK3CA—pancreatic cancer	3.84e-05	0.000337	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	3.84e-05	0.000337	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—KRAS—pancreatic cancer	3.81e-05	0.000335	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	3.79e-05	0.000333	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CB—pancreatic cancer	3.72e-05	0.000327	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PRSS1—pancreatic cancer	3.71e-05	0.000326	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—HRAS—pancreatic cancer	3.71e-05	0.000326	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CTNNB1—pancreatic cancer	3.63e-05	0.000319	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CXCL8—pancreatic cancer	3.58e-05	0.000314	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP9—pancreatic cancer	3.56e-05	0.000313	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HRAS—pancreatic cancer	3.55e-05	0.000312	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—HRAS—pancreatic cancer	3.55e-05	0.000312	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CD44—pancreatic cancer	3.47e-05	0.000305	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—AKT1—pancreatic cancer	3.45e-05	0.000304	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CASP3—pancreatic cancer	3.42e-05	0.000301	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—HRAS—pancreatic cancer	3.41e-05	0.0003	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—HRAS—pancreatic cancer	3.41e-05	0.0003	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	3.37e-05	0.000296	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IFNA1—pancreatic cancer	3.37e-05	0.000296	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCND1—pancreatic cancer	3.33e-05	0.000293	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CTNNB1—pancreatic cancer	3.3e-05	0.00029	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—HRAS—pancreatic cancer	3.29e-05	0.000289	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—HRAS—pancreatic cancer	3.29e-05	0.000289	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—SRC—pancreatic cancer	3.28e-05	0.000288	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT1—pancreatic cancer	3.27e-05	0.000288	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—HRAS—pancreatic cancer	3.24e-05	0.000285	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MMP9—pancreatic cancer	3.23e-05	0.000284	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ARG2—pancreatic cancer	3.22e-05	0.000283	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTEN—pancreatic cancer	3.21e-05	0.000283	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—pancreatic cancer	3.2e-05	0.000281	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PRSS1—pancreatic cancer	3.19e-05	0.00028	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—STAT3—pancreatic cancer	3.16e-05	0.000278	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NRAS—pancreatic cancer	3.16e-05	0.000278	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT1—pancreatic cancer	3.14e-05	0.000276	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IFNA2—pancreatic cancer	3.13e-05	0.000275	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT1—pancreatic cancer	3.13e-05	0.000275	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT1—pancreatic cancer	3.01e-05	0.000264	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT1—pancreatic cancer	3.01e-05	0.000264	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SRC—pancreatic cancer	2.98e-05	0.000262	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	2.94e-05	0.000258	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TGFB1—pancreatic cancer	2.93e-05	0.000258	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—pancreatic cancer	2.9e-05	0.000255	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT1—pancreatic cancer	2.9e-05	0.000255	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT1—pancreatic cancer	2.9e-05	0.000255	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EGFR—pancreatic cancer	2.88e-05	0.000253	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—STAT3—pancreatic cancer	2.88e-05	0.000253	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NRAS—pancreatic cancer	2.87e-05	0.000252	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TYMP—pancreatic cancer	2.81e-05	0.000247	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ARG2—pancreatic cancer	2.77e-05	0.000243	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—pancreatic cancer	2.74e-05	0.000241	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—KRAS—pancreatic cancer	2.72e-05	0.000239	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—pancreatic cancer	2.67e-05	0.000235	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TGFB1—pancreatic cancer	2.67e-05	0.000234	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGFR—pancreatic cancer	2.61e-05	0.00023	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KRAS—pancreatic cancer	2.47e-05	0.000217	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TYMP—pancreatic cancer	2.42e-05	0.000212	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	2.36e-05	0.000207	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HRAS—pancreatic cancer	2.31e-05	0.000203	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	2.29e-05	0.000202	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CA—pancreatic cancer	2.27e-05	0.000199	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GLP1R—pancreatic cancer	2.27e-05	0.000199	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—DPYD—pancreatic cancer	2.23e-05	0.000196	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLAU—pancreatic cancer	2.22e-05	0.000195	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—pancreatic cancer	2.19e-05	0.000193	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	2.12e-05	0.000186	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	2.11e-05	0.000185	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRAS—pancreatic cancer	2.1e-05	0.000184	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—pancreatic cancer	2.04e-05	0.000179	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.99e-05	0.000175	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CG—pancreatic cancer	1.98e-05	0.000174	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EGF—pancreatic cancer	1.95e-05	0.000172	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GLP1R—pancreatic cancer	1.95e-05	0.000171	CbGpPWpGaD
Rufinamide—ALB—Metabolism—DPYD—pancreatic cancer	1.92e-05	0.000169	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—pancreatic cancer	1.85e-05	0.000163	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC2A2—pancreatic cancer	1.82e-05	0.00016	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.8e-05	0.000158	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	1.79e-05	0.000158	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CD—pancreatic cancer	1.74e-05	0.000153	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.74e-05	0.000153	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.72e-05	0.000151	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CD44—pancreatic cancer	1.64e-05	0.000144	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.58e-05	0.000139	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GCG—pancreatic cancer	1.57e-05	0.000138	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CB—pancreatic cancer	1.52e-05	0.000133	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.49e-05	0.000131	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—STK11—pancreatic cancer	1.48e-05	0.00013	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.46e-05	0.000129	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CD44—pancreatic cancer	1.41e-05	0.000124	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.38e-05	0.000121	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.37e-05	0.00012	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GCG—pancreatic cancer	1.35e-05	0.000119	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.3e-05	0.000115	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TYMS—pancreatic cancer	1.27e-05	0.000112	CbGpPWpGaD
Rufinamide—ALB—Metabolism—STK11—pancreatic cancer	1.27e-05	0.000112	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SRC—pancreatic cancer	1.21e-05	0.000107	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.19e-05	0.000105	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—pancreatic cancer	1.18e-05	0.000104	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NRAS—pancreatic cancer	1.17e-05	0.000103	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TYMS—pancreatic cancer	1.09e-05	9.6e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TGFB1—pancreatic cancer	1.09e-05	9.54e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.05e-05	9.25e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.03e-05	9.1e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOE—pancreatic cancer	1.03e-05	9.09e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—pancreatic cancer	1.01e-05	8.84e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	9.82e-06	8.63e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	9.33e-06	8.2e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CA—pancreatic cancer	9.24e-06	8.12e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARG—pancreatic cancer	9e-06	7.91e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—pancreatic cancer	8.94e-06	7.86e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOE—pancreatic cancer	8.88e-06	7.81e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HRAS—pancreatic cancer	8.55e-06	7.51e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.41e-06	7.39e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	8.2e-06	7.21e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CG—pancreatic cancer	8.02e-06	7.05e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARG—pancreatic cancer	7.74e-06	6.8e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CD44—pancreatic cancer	7.6e-06	6.69e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—pancreatic cancer	7.55e-06	6.63e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GCG—pancreatic cancer	7.29e-06	6.41e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	7.15e-06	6.28e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—pancreatic cancer	7.08e-06	6.23e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CD—pancreatic cancer	7.05e-06	6.2e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—STK11—pancreatic cancer	6.86e-06	6.03e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTEN—pancreatic cancer	6.18e-06	5.43e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CB—pancreatic cancer	6.14e-06	5.4e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—pancreatic cancer	6.09e-06	5.35e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.9e-06	5.18e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTEN—pancreatic cancer	5.31e-06	4.67e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOE—pancreatic cancer	4.8e-06	4.22e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	4.36e-06	3.83e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.33e-06	3.8e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.18e-06	3.67e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.8e-06	3.34e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CA—pancreatic cancer	3.75e-06	3.29e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—pancreatic cancer	3.56e-06	3.13e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.32e-06	2.92e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.29e-06	2.89e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—pancreatic cancer	3.06e-06	2.69e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.87e-06	2.52e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.02e-06	1.78e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.65e-06	1.45e-05	CbGpPWpGaD
